Exabis Library
Welcome to the e-CCO Library!
P146 Comparison of three histologic indices in ulcerative colitis: Evaluation from the Phase 2 study of upadacitinib (U-ACHIEVE)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P146: Dysplasia Surveillance in inflammatory bowel disease—a cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P146: Initial response to induction treatment more important than type of induction treatment for achieving sustained steroid free remission at 1 year in new-onset paediatric Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P146: Primary intestinal Epstein-Barr virus-associated NK/T-Cell lymphoproliferative disorder: a disease mimicking IBD
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P146: Risk factors of clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission.
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P146: Stigmatization and resilience in inflammatory bowel disease patients at one-year follow-up
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P146: The Toronto IBD global endoscopic reporting (TIGER) score demonstrates significant correlation with fecal calprotectin, CRP and IBD Disk in Crohn's disease patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P146: Ultrasonography and perianal involvement in inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P147 Systematic review: diverting loop ileostomy as treatment option in severe inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P147: Do IBD Patient Treatment Outcomes Expectations Differ by Ethnicity and Gender?
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P147: Metabolomics discriminate children with Crohn's disease from ulcerative colitis and from healthy controls – preliminary study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P147: Presence of granulomas in tissue samples from Crohn’s disease patients correlates with specific disease characteristics
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P147: Progression to biologic treatment in very early onset inflammatory bowel disease patients- a long term follow up retrospective study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P147: The valuation of the Short Inflammatory Bowel Disease Questionnaire for use in economic evaluations
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P147: Thromboembolic complications in patients with Inflammatory bowel disease predict poor prognosis: a large North Indian cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P147: Trends in choice of first line biologic therapy for patients with Inflammatory Bowel Disease. An observational cohort study.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P148 Reproducibility of PICaSSO score by using narrow banding images (NBI) to assess mucosal and histological healing in ulcerative colitis (UC) patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P148: ANA and Anti-dsDNA antibody enabling the prediction of inflammatory arthritis in inflammatory bowel disease.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P148: Fecal calprotectin as a noninvasive indicator for ulcerative colitis disease activity in the Korean cohort
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM